Company Performance - Palmer Square Capital BDC Inc. reported quarterly earnings of $0.43 per share, exceeding the Zacks Consensus Estimate of $0.41 per share, but down from $0.48 per share a year ago, representing an earnings surprise of +4.88% [1] - The company posted revenues of $31.69 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.63%, but down from $37.31 million year-over-year [2] - Over the last four quarters, the company has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Performance - Palmer Square Capital BDC Inc. shares have declined approximately 20.1% since the beginning of the year, contrasting with the S&P 500's gain of 15.1% [3] - The current Zacks Rank for the stock is 3 (Hold), indicating that shares are expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.41 on revenues of $30.1 million, and for the current fiscal year, it is $1.64 on revenues of $122.99 million [7] - The estimate revisions trend for Palmer Square Capital BDC Inc. was mixed ahead of the earnings release, and future estimates may change following the recent earnings report [6] Industry Context - The Financial - SBIC & Commercial Industry, to which Palmer Square Capital BDC Inc. belongs, is currently ranked in the bottom 21% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Core Insights - Avanos Medical reported quarterly earnings of $0.22 per share, exceeding the Zacks Consensus Estimate of $0.16 per share, but down from $0.36 per share a year ago, representing an earnings surprise of +37.50% [1] - The company achieved revenues of $177.8 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 6.88% and up from $170.4 million year-over-year [2] Financial Performance - Over the last four quarters, Avanos Medical has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] - The current consensus EPS estimate for the upcoming quarter is $0.29 on revenues of $176.14 million, and for the current fiscal year, it is $0.92 on revenues of $684.98 million [7] Market Position - Avanos Medical shares have declined approximately 29% since the beginning of the year, contrasting with the S&P 500's gain of 15.1% [3] - The Zacks Industry Rank places the Medical - Instruments sector in the top 37% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] Future Outlook - The sustainability of the stock's price movement will depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The current Zacks Rank for Avanos Medical is 3 (Hold), suggesting that the shares are expected to perform in line with the market in the near future [6]

Core Insights - Iron Mountain (IRM) reported quarterly earnings of $1.32 per share, exceeding the Zacks Consensus Estimate of $1.29 per share, and showing significant growth from $0.42 per share a year ago, resulting in an earnings surprise of +2.33% [1] - The company posted revenues of $1.75 billion for the quarter ended September 2025, slightly missing the Zacks Consensus Estimate by 0.09%, but up from $1.56 billion year-over-year [2] - Iron Mountain has underperformed the market, with shares down about 1.7% year-to-date compared to the S&P 500's gain of 15.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.37 on revenues of $1.81 billion, and for the current fiscal year, it is $5.09 on revenues of $6.87 billion [7] - The estimate revisions trend for Iron Mountain was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Business - Information Services industry, to which Iron Mountain belongs, is currently in the top 41% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - Wolverine World Wide (WWW) reported quarterly earnings of $0.36 per share, exceeding the Zacks Consensus Estimate of $0.33 per share, and showing an increase from $0.29 per share a year ago, resulting in an earnings surprise of +9.09% [1] - The company achieved revenues of $470.3 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.51% and up from $440.2 million year-over-year [2] - Wolverine has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] Earnings Outlook - The future performance of Wolverine's stock will largely depend on management's commentary during the earnings call and the sustainability of the stock's immediate price movement based on recent earnings and future expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.46 on revenues of $518.74 million, and for the current fiscal year, it is $1.33 on revenues of $1.87 billion [7] Industry Context - The Shoes and Retail Apparel industry, to which Wolverine belongs, is currently ranked in the bottom 28% of over 250 Zacks industries, which may impact stock performance [8] - Caleres Inc. (CAL), another company in the same industry, is expected to report quarterly earnings of $0.75 per share, reflecting a year-over-year decline of -39% [9]

Core Insights - Cencora reported quarterly earnings of $3.84 per share, exceeding the Zacks Consensus Estimate of $3.79 per share, and showing an increase from $3.34 per share a year ago, resulting in an earnings surprise of +1.32% [1] - The company achieved revenues of $83.73 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.69% and reflecting a year-over-year increase from $79.05 billion [2] - Cencora's stock has increased by approximately 53.3% since the beginning of the year, significantly outperforming the S&P 500's gain of 15.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $4.05, with projected revenues of $87.22 billion, and for the current fiscal year, the EPS estimate is $17.37 on revenues of $342.35 billion [7] - The estimate revisions trend for Cencora was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical Services industry, to which Cencora belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, suggesting that the industry's outlook may impact stock performance [8] - Another company in the same industry, Ardent Health, is expected to report quarterly earnings of $0.42 per share, reflecting a year-over-year change of +121.1%, with revenues anticipated to be $1.55 billion, up 7.1% from the previous year [9][10]

分组1 - Taboola.com Ltd. reported quarterly earnings of $0.11 per share, exceeding the Zacks Consensus Estimate of $0.10 per share, compared to a loss of $0.02 per share a year ago, representing an earnings surprise of +10.00% [1] - The company posted revenues of $496.76 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 6.69%, and showing an increase from year-ago revenues of $433.01 million [2] - Over the last four quarters, Taboola.com has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] 分组2 - The stock has underperformed the market, losing about 8.8% since the beginning of the year, while the S&P 500 gained 15.1% [3] - The current consensus EPS estimate for the coming quarter is $0.19 on revenues of $514.9 million, and for the current fiscal year, it is $0.45 on revenues of $1.87 billion [7] - The Computers - IT Services industry, to which Taboola.com belongs, is currently in the top 30% of Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Core Insights - National Vision reported quarterly earnings of $0.13 per share, exceeding the Zacks Consensus Estimate of $0.12 per share, and showing an earnings surprise of +8.33% [1] - The company achieved revenues of $487.33 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.69% and reflecting a year-over-year increase from $451.52 million [2] - National Vision's stock has increased approximately 145.7% year-to-date, significantly outperforming the S&P 500's gain of 15.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.05 on revenues of $490.34 million, and for the current fiscal year, it is $0.68 on revenues of $1.96 billion [7] - The trend of estimate revisions for National Vision was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Consumer Products - Staples industry, to which National Vision belongs, is currently ranked in the bottom 18% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor sentiment and stock performance [5]

Core Insights - Humana reported quarterly earnings of $3.24 per share, exceeding the Zacks Consensus Estimate of $2.91 per share, but down from $4.16 per share a year ago, indicating an earnings surprise of +11.34% [1] - The company achieved revenues of $32.65 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.09% and up from $29.3 billion year-over-year [2] - Humana has outperformed consensus EPS estimates three times in the last four quarters and has also topped revenue estimates three times during the same period [2] Earnings Outlook - The future performance of Humana's stock will largely depend on management's commentary during the earnings call and the sustainability of the stock's immediate price movement based on the recently released numbers [3][4] - The current consensus EPS estimate for the upcoming quarter is -$3.70 on revenues of $31.77 billion, while for the current fiscal year, it is $17.05 on revenues of $128.21 billion [7] Industry Context - The Medical - HMOs industry, to which Humana belongs, is currently ranked in the bottom 26% of over 250 Zacks industries, suggesting that the overall industry outlook may negatively impact Humana's stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors or through tools like the Zacks Rank [5][6]

Core Insights - Equitable Holdings, Inc. (EQH) reported quarterly earnings of $1.48 per share, missing the Zacks Consensus Estimate of $1.59 per share, and showing a decrease from $1.53 per share a year ago, resulting in an earnings surprise of -6.92% [1] - The company posted revenues of $3.74 billion for the quarter ended September 2025, which was 6.01% below the Zacks Consensus Estimate and a decline from $3.78 billion year-over-year [2] - Equitable Holdings has only surpassed consensus EPS estimates once in the last four quarters and has not beaten consensus revenue estimates during the same period [2] Company Performance - Equitable Holdings shares have increased by approximately 3.4% since the beginning of the year, while the S&P 500 has gained 16.5% [3] - The current consensus EPS estimate for the upcoming quarter is $1.77 on revenues of $3.79 billion, and for the current fiscal year, it is $5.78 on revenues of $14.88 billion [7] Industry Context - The Zacks Industry Rank for Insurance - Multi line, to which Equitable Holdings belongs, is currently in the top 36% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Equitable Holdings' stock performance [5]

Core Insights - Accel Entertainment reported quarterly earnings of $0.24 per share, exceeding the Zacks Consensus Estimate of $0.20 per share, and showing an increase from $0.22 per share a year ago, resulting in an earnings surprise of +20.00% [1] - The company generated revenues of $329.69 million for the quarter ended September 2025, which was slightly below the Zacks Consensus Estimate by 0.36%, but an increase from $302.23 million year-over-year [2] - Accel Entertainment has surpassed consensus EPS estimates three times over the last four quarters and has topped consensus revenue estimates two times in the same period [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.21 on revenues of $341.07 million, while for the current fiscal year, the estimate is $0.90 on revenues of $1.33 billion [7] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Gaming industry, to which Accel Entertainment belongs, is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% of industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]